PCV56 COST-EFFECTIVENESS OF DABIGATRAN ETEXILATE 150 MG FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN PATIENTS UNDERGOING TOTAL HIP OR KNEE ARTHROPLASTY THAT HAVE MODERATE IMPAIRMENT OF RENAL FUNCTION
Abstract
Authors
S Wolowacz N Roskell J Plumb A Clemens P Robinson G Dolan I Brenkel